Publications by authors named "Goran Santak"

Article Synopsis
  • BPC 157, a stable gastric pentadecapeptide, shows potential in treating major vessel occlusion syndromes by activating collateral pathways and improving venous system function in rats.
  • In a study simulating abdominal compartment syndrome, rats receiving BPC 157 had significant recovery from intra-abdominal hypertension and associated complications, including hemorrhagic lesions and brain swelling.
  • The treatment prevented serious health issues like severe ECG disturbances, organ congestion, and damage, indicating that BPC 157 effectively cured primary abdominal compartment syndrome.
View Article and Find Full Text PDF

Background: Soft-tissue osteosarcomas are very rare. Only three cases of extraskeletal osteosarcoma have been reported arising in colon and we report the first well differentiated one.

Patients And Methods: A 58-year-old woman was admitted to our hospital with a history of pain and swelling in lower right abdomen for the last 3 months.

View Article and Find Full Text PDF

The piezoelectric properties of some natural crystals and polymers can also be used in surgery. For this purpose, a prototype of an endoscopic instrument was constructed with piezoelectric material attached to its working end with the aim of recognizing pulsating blood vessels during laparoscopic surgery. To test the properties of the new instrument in laboratory conditions, simulated blood circulation was used with the possibility of changing pressure and frequency.

View Article and Find Full Text PDF

Background: In the present work, we compared the antitumor effects of native human interferon-α (IFN-α) (nHuIFN-α) and recombinant human IFN-α (rHuIFN-α) on human lung adenocarcinoma A549 cells.

Materials And Methods: The antitumor activity was determined by measuring cell viability and apoptosis, while the abundance of mRNA, measured by polymerase chain reaction (PCR), determined the potential role of p21 and survivin in antitumor activity of nHuIFN-α.

Results: The results show that nHuIFN-α significantly reduced A549 cell viability, compared to rHuIFN-α.

View Article and Find Full Text PDF

Background: Commercial preparations of native human interferon alpha (nHuIFN-alpha) contain several subtypes of interferon-alpha (IFN-alpha) and traces of other cytokines. Recently, we described its antifibrotic potential and showed nHuIFN-alpha to have a greater effect than that of recombinant human IFN-alpha (rHuIFN-alpha). We hypothesized that cooperation between different cytokines in the nHuIFN-alpha preparation is essential for this effect.

View Article and Find Full Text PDF

Interferon-alpha(IFN-alpha) inhibits fibroblast proliferation, differentiation into myofibroblasts, and extracellular matrix synthesis, which are key events during both normal wound repair and fibrotic lesion formation. Unlike recombinant human IFN-alpha (rHuIFN-alpha), a native human IFN-alpha (nHuIFN-alpha) consists of several IFN-alpha subtypes and traces of other cytokines produced by the Sendai virus-stimulated human leukocytes. This study compares the antifibrotic effect of nHuIFN-alpha and rHuIFN-alpha in normal human dermal fibroblasts (HDFs).

View Article and Find Full Text PDF